ArticleLife medicine2025

Integration of a novel anti-PD-1 antibody with chimeric antigen receptor-T engineered to express interleukin-7 enhances targeting efficacy against lung cancer.

Chenxi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.